Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001580495 | SCV000535171 | likely benign | not provided | 2021-08-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000468666 | SCV000554292 | likely benign | Alstrom syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Personalized Diabetes Medicine Program, |
RCV001172526 | SCV001335579 | likely benign | Monogenic diabetes | 2017-02-17 | criteria provided, single submitter | research | ACMG criteria: PP3 (3 predictors), BS1 (1% in 1000G-AFR), BP4 (4 predictors), BP1 (truncating known to cause disease), (BS2)for 1 homozygote in ExAC=Likely Benign |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000436669 | SCV001363240 | benign | not specified | 2019-09-23 | criteria provided, single submitter | clinical testing | Variant summary: ALMS1 c.6079T>C, also referred to as c.6085T>C using the refseq HGVS naming convention (p.Ser2027Pro), results in a non-conservative amino acid change located in the Alstrom syndrome repeat domain (IPR040972) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00039 in 249198 control chromosomes, predominantly at a frequency of 0.0055 within the African or African-American subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 2.5 fold of the estimated maximal expected allele frequency for a pathogenic variant in ALMS1 causing Cardiomyopathy phenotype (0.0022), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.6079T>C in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Clinical Genomics, |
RCV000468666 | SCV002605258 | uncertain risk allele | Alstrom syndrome | criteria provided, single submitter | research | Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs149096794 in Alstrom syndrome yet. | |
Ambry Genetics | RCV002356622 | SCV002657761 | benign | Cardiovascular phenotype | 2019-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000468666 | SCV002807321 | likely benign | Alstrom syndrome | 2021-11-15 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000468666 | SCV003919971 | uncertain significance | Alstrom syndrome | 2021-03-30 | criteria provided, single submitter | clinical testing | ALMS1 NM_015120.4 exon 8 p.Ser2027Pro (c.6079T>C): This variant has not been reported in the literature but is present in 0.5% (129/24192) of African alleles in the Genome Aggregation Database, including one homozygote (https://gnomad.broadinstitute.org/variant/2-73679736-T-C). This variant is present in ClinVar (Variation ID:391989). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |